11.00
-0.06
(-0.54%)
At close: January 10 at 4:00:01 PM EST
10.51
-0.49
(-4.45%)
After hours: January 10 at 7:39:26 PM EST
Breakdown
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Assets
52,210.00
4,464.00
5,973.00
21,379.00
Total Liabilities Net Minority Interest
4,962.00
4,262.00
3,091.00
1,369.00
Total Equity Gross Minority Interest
47,248.00
202.00
2,882.00
20,010.00
Total Capitalization
47,248.00
202.00
2,882.00
20,010.00
Common Stock Equity
47,248.00
202.00
2,882.00
20,010.00
Capital Lease Obligations
284.00
559.00
811.00
213.00
Net Tangible Assets
47,248.00
202.00
2,882.00
20,010.00
Working Capital
46,750.00
-249.00
2,288.00
19,239.00
Invested Capital
47,248.00
202.00
2,882.00
20,010.00
Tangible Book Value
47,248.00
202.00
2,882.00
20,010.00
Total Debt
284.00
559.00
811.00
213.00
Share Issued
10,086.12
1,645.95
480.69
480.69
Ordinary Shares Number
10,086.12
1,645.95
480.69
480.69
6/30/2021 - 6/24/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCAX Bicara Therapeutics Inc.
14.38
-5.70%
LXEO Lexeo Therapeutics, Inc.
6.39
-6.30%
PCVX Vaxcyte, Inc.
81.08
+0.02%
VIGL Vigil Neuroscience, Inc.
1.7900
-2.72%
MLYS Mineralys Therapeutics, Inc.
9.87
-11.87%
XBIO Xenetic Biosciences, Inc.
3.8600
-4.22%
OVID Ovid Therapeutics Inc.
0.8207
-9.80%
AVBP ArriVent BioPharma, Inc.
24.88
-7.37%
ASND Ascendis Pharma A/S
129.19
-3.90%
CLYM Climb Bio, Inc.
2.0000
+6.95%